Search

everythinglearnresearchcommunity

for

Search:↓

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Once-daily 5% minoxidil foam and twice-daily 2% minoxidil solution are similarly effective and safe for female pattern hair loss.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The botanical treatment for hair loss shows promise, especially for children.

GI197111X is best dissolved in Capmul MCM for trials.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Using 5% minoxidil foam twice daily can help regrow hair, especially in younger men aged 20-30.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Promising cancer treatments were found, but the manufacturer closed.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.